Glypican 1 and syndecan 1 differently regulate noradrenergic hypertension development: Focus on IP3R and calcium
Simone R. Potje, Ayman Isbatan, Rita C. Tostes, Lusiane Maria Bendhack, Randal O. Dull, João L. Carvalho-de-Souza, Andréia Z. Chignalia
Topics & Concepts
VasoconstrictionCalciumSyndecan 1EndocrinologyBlood pressureInternal medicineNorepinephrineCalcium signalingPathophysiology of hypertensionNitric oxideCell biologySignal transductionMedicineChemistryBiologyBiochemistryCellDopamineProteoglycans and glycosaminoglycans researchNitric Oxide and Endothelin EffectsPulmonary Hypertension Research and Treatments